Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jan-24 4:05 PM View:  | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 2,879 | $1.91 | $5,498.89 | (5%) 59.58K to 56.7K | |
| 23-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 8,000 | -- | -- | 35% 22.74K to 30.74K | |
| 23-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 59,000 | -- | -- | 7% 892.87K to 951.87K | |
| 23-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 904 | $1.91 | $1,726.64 | (3%) 30.74K to 29.84K | |
| 23-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 7,803 | $1.91 | $14,903.70 | (< 1%) 951.87K to 944.06K | |
| 23-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 23,000 | -- | -- | 27% 84.34K to 107.34K | |
| 23-Jan-24 4:05 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 23,000 | -- | -- | 63% 36.58K to 59.58K | |
| 23-Jan-24 4:05 PM View: | Fabbio Patrick Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Grant | 22,000 | -- | -- | 100% 0 to 22.0K | |
| 23-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-24 | Payment of Exercise | 3,049 | $1.91 | $5,823.59 | (3%) 107.34K to 104.3K | |
| 12-Jan-24 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 5,229 | $2.39 | $12,497.30 | (6%) 89.57K to 84.34K | |
| 12-Jan-24 4:05 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 1,877 | $2.39 | $4,486.03 | (5%) 38.46K to 36.58K | |
| 12-Jan-24 4:05 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-24 | Payment of Exercise | 5,746 | $2.39 | $13,732.90 | (< 1%) 898.61K to 892.87K | |
| 05-Jan-24 4:30 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 5,840 | $2.17 | $12,672.80 | (< 1%) 904.45K to 898.61K | |
| 05-Jan-24 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 324 | $2.17 | $703.08 | (1%) 23.06K to 22.74K | |
| 05-Jan-24 4:35 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-24 | Payment of Exercise | 1,899 | $2.17 | $4,120.83 | (2%) 91.47K to 89.57K | |
| 18-Jul-23 4:05 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 17-Jul-23 | Payment of Exercise | 10,075 | $2.56 | $25,792.00 | (30%) 33.14K to 23.06K | |
| 05-Jul-23 10:00 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 03-Jul-23 | Payment of Exercise | 682 | $2.46 | $1,677.72 | (2%) 39.14K to 38.46K | |
| 27-Jun-23 7:26 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 27-Jun-23 | Gift | 7,420 | -- | -- | (< 1%) 911.87K to 904.45K | |
| 27-Jun-23 7:26 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 23-Jun-23 | Gift | 1,890 | -- | -- | (< 1%) 913.76K to 911.87K | |
| 20-Jan-23 4:00 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 51,300 | -- | -- | 6% 866.98K to 918.28K | |
| 20-Jan-23 4:00 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 5,900 | -- | -- | 22% 27.24K to 33.14K | |
| 20-Jan-23 4:00 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 19,900 | -- | -- | 28% 71.57K to 91.47K | |
| 20-Jan-23 4:00 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 19-Jan-23 | Grant | 20,700 | -- | -- | 112% 18.44K to 39.14K | |
| 11-Jan-23 4:05 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,225 | $3.00 | $15,675.00 | (7%) 76.8K to 71.57K | |
| 11-Jan-23 4:02 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 1,876 | $3.00 | $5,628.00 | (9%) 20.32K to 18.44K | |
| 11-Jan-23 4:03 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-23 | Payment of Exercise | 5,855 | $3.00 | $17,565.00 | (< 1%) 872.84K to 866.98K | |
| 04-Jan-23 4:24 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 361 | $2.80 | $1,010.80 | (1%) 27.6K to 27.24K | |
| 04-Jan-23 4:26 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 2,159 | $2.80 | $6,045.20 | (3%) 78.96K to 76.8K | |
| 04-Jan-23 4:25 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-23 | Payment of Exercise | 6,604 | $2.80 | $18,491.20 | (< 1%) 879.44K to 872.84K | |
| 30-Dec-22 6:00 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 30-Dec-22 | Private Sale | 15,473 | $2.71 | $41,948.90 | < 1% 2.68M to 2.69M | |
| 15-Sep-22 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 15-Sep-22 | Purchase | 7,300 | $3.80 | $27,740.00 | < 1% 2.7M to 2.71M | |
| 15-Sep-22 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 14-Sep-22 | Private Purchase | 16,600 | $3.98 | $66,068.00 | < 1% 2.68M to 2.7M | |
| 15-Aug-22 5:49 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 11-Aug-22 | Private Purchase | 9,065 | $3.84 | $34,809.60 | 1% 870.38K to 879.44K | |
| 19-Jul-22 4:06 PM View: | Fry Hannah VP, Controller | Protara Therapeutics, Inc. (TARA) | 16-Jul-22 | Grant | 25,000 | -- | -- | 962% 2.6K to 27.6K | |
| 19-Jul-22 4:31 PM View: | Davis Blaine Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 15-Jul-22 | Payment of Exercise | 5,081 | $3.13 | $15,903.50 | (20%) 25.74K to 20.66K | |
| 05-Jul-22 5:00 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 01-Jul-22 | Payment of Exercise | 682 | $3.22 | $2,196.04 | (3%) 21.0K to 20.32K | |
| 05-Jul-22 5:00 PM View: | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 30-Jun-22 | Private Purchase | 10,000 | $3.10 | $31,000.00 | 5% 188.0K to 198.0K | |
| 10-Feb-23 10:00 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 27-Jun-22 | Gift | 4,519 | -- | -- | (< 1%) 918.28K to 913.76K | |
| 08-Apr-22 6:45 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 08-Apr-22 | Purchase | 7,791 | $4.80 | $37,364.10 | < 1% 2.55M to 2.56M | |
| 08-Apr-22 6:45 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 07-Apr-22 | Private Purchase | 2,345 | $4.74 | $11,122.80 | < 1% 2.67M to 2.68M | |
| 16-Mar-22 4:37 PM View: | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 14-Mar-22 | Private Purchase | 10,000 | $4.25 | $42,500.00 | 6% 178.0K to 188.0K | |
| 14-Mar-22 4:37 PM View: | Beshar Luke M Director | Protara Therapeutics, Inc. (TARA) | 10-Mar-22 | Private Purchase | 10,000 | $4.46 | $44,555.00 | 6% 168.0K to 178.0K | |
| 31-Jan-22 4:05 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 28-Jan-22 | Private Purchase | 24,031 | $4.96 | $119,271.00 | < 1% 2.65M to 2.67M | |
| 12-Jan-22 5:18 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Payment of Exercise | 5,080 | $6.27 | $31,851.60 | (< 1%) 877.5K to 872.42K | 0% |
| 12-Jan-22 5:20 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Payment of Exercise | 4,603 | $6.27 | $28,860.80 | (6%) 83.56K to 78.96K | 0% |
| 12-Jan-22 5:16 PM View: | Bandari Jathin Chief Medical Officer | Protara Therapeutics, Inc. (TARA) | 10-Jan-22 | Grant | 13,500 | -- | -- | 100% 0 to 13.5K | |
| 05-Jan-22 4:35 PM View: | Davis Blaine Chief Financial Officer | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 14,100 | -- | -- | 952% 1.48K to 15.58K | |
| 05-Jan-22 4:36 PM View: | Shefferman Jesse CEO and President Director | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 42,300 | -- | -- | 5% 835.21K to 877.5K | |
| 05-Jan-22 4:37 PM View: | Zummo Jacqueline Chf Scientific Operations Off | Protara Therapeutics, Inc. (TARA) | 03-Jan-22 | Grant | 14,100 | -- | -- | 20% 69.46K to 83.56K | |
| 29-Dec-21 7:36 PM View: | Opaleye Management Inc. 10% Owner | Protara Therapeutics, Inc. (TARA) | 29-Dec-21 | Market Purchase | 4,500 | $6.98 | $31,407.80 | < 1% 2.65M to 2.65M | (9%) |
